These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12421739)

  • 1. Therapy of pulmonary hypertension: the evolution from vasodilators to antiproliferative agents.
    Rubin LJ
    Am J Respir Crit Care Med; 2002 Nov; 166(10):1308-9. PubMed ID: 12421739
    [No Abstract]   [Full Text] [Related]  

  • 2. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.
    Nishimura T; Faul JL; Berry GJ; Vaszar LT; Qiu D; Pearl RG; Kao PN
    Am J Respir Crit Care Med; 2002 Nov; 166(10):1403-8. PubMed ID: 12406854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial hypertension: new insights and new hope.
    Martin KB; Klinger JR; Rounds SI
    Respirology; 2006 Jan; 11(1):6-17. PubMed ID: 16423196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the simvastatin effects in the treatment of pulmonary hypertension (PH).
    Shahmiri SS; Adeli SH; Mousavi SA; Mostafapour E; Fereshtehnejad SM; Namegh B; Ziaeenejad MT
    Lijec Vjesn; 2009 Nov; 131 Suppl 6():12-5. PubMed ID: 22046626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortic stenosis and lipids: does intervention work?
    Wierzbicki AS; Viljoen A; Chambers JB
    Curr Opin Cardiol; 2010 Jul; 25(4):379-84. PubMed ID: 20414108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin prevents dehydromonocrotaline-induced pulmonary hypertension in beagles.
    Chen D; Zhou D; Qian J; Chen F; Guan L; Dong L; Ge J
    Exp Lung Res; 2012 Sep; 38(7):333-43. PubMed ID: 22888849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safe use of ezetimibe plus simvastatin in high-risk vascular patients (with chronic kidney disease and PAD).
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):227-8. PubMed ID: 21881698
    [No Abstract]   [Full Text] [Related]  

  • 8. [4S [Scandinavian Simvastatin Survival Study]].
    Koizumi J; Yoshida I
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():410-5. PubMed ID: 11347105
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arteriosclerosis: how plaque heals].
    Neumaier J
    MMW Fortschr Med; 2002 Dec; 144(51-52):9. PubMed ID: 12596673
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 11. Heart protection study finds simvastatin reduces vascular risk in a wide range of high-risk patients.
    Collins R
    Am J Manag Care; 2002 Jan; Suppl():6. PubMed ID: 11833455
    [No Abstract]   [Full Text] [Related]  

  • 12. Statin therapy is associated with decreased pulmonary vascular pressures in severe COPD.
    Reed RM; Iacono A; DeFilippis A; Jones S; Eberlein M; Lechtzin N; Girgis RE
    COPD; 2011 Apr; 8(2):96-102. PubMed ID: 21495837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.
    Nishimura T; Vaszar LT; Faul JL; Zhao G; Berry GJ; Shi L; Qiu D; Benson G; Pearl RG; Kao PN
    Circulation; 2003 Sep; 108(13):1640-5. PubMed ID: 12963647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should patients with pulmonary hypertension and increased pulmonary resistance be treated with vasodilators?
    Rich S
    Cardiovasc Clin; 1990; 21(1):265-74; discussion 275-6. PubMed ID: 2199052
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment with statins for the reduction of cardiovascular risk].
    Chiariello M
    Ital Heart J Suppl; 2001 Mar; 2(3):221-3. PubMed ID: 11307779
    [No Abstract]   [Full Text] [Related]  

  • 16. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In brief: Zetia and Vytorin: the ENHANCE study.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined effects of the ATP-sensitive potassium channel opener pinacidil and simvastatin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
    Jiang L; Zhou T; Liu H
    Pharmazie; 2012 Jun; 67(6):547-52. PubMed ID: 22822545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615
    [No Abstract]   [Full Text] [Related]  

  • 20. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.